A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Spectrally separated dual-label upconversion luminescence lateral flow assay for cancer-specific STn-glycosylation in CA125 and CA15-3




TekijätEkman Miikka, Salminen Teppo, Raiko Kirsti, Soukka Tero, Gidwani Kamlesh, Martiskainen Iida

KustantajaSpringer Nature

Julkaisuvuosi2024

JournalAnalytical and Bioanalytical Chemistry

Tietokannassa oleva lehden nimiAnalytical and bioanalytical chemistry

Lehden akronyymiAnal Bioanal Chem

Vuosikerta416

Numero13

Aloitussivu3251

Lopetussivu3260

ISSN1618-2642

eISSN1618-2650

DOIhttps://doi.org/10.1007/s00216-024-05275-z

Verkko-osoitehttps://link.springer.com/article/10.1007/s00216-024-05275-z

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/387617668


Tiivistelmä
Multiplexed lateral flow assays (LFAs) offer efficient on-site testing by simultaneously detecting multiple biomarkers from a single sample, reducing costs. In cancer diagnostics, where biomarkers can lack specificity, multiparameter detection provides more information at the point-of-care. Our research focuses on epithelial ovarian cancer (EOC), where STn-glycosylated forms of CA125 and CA15-3 antigens can better discriminate cancer from benign conditions. We have developed a dual-label LFA that detects both CA125-STn and CA15-3-STn within a single anti-STn antibody test line. This utilizes spectral separation of green (540 nm) and blue (450 nm) emitting erbium (NaYF4:Yb3+, Er3+)- and thulium (NaYF4: Yb3+, Tm3+)-doped upconverting nanoparticle (UCNP) reporters conjugated with antibodies against the protein epitopes in CA125 or CA15-3. This technology allows the simultaneous detection of different antigen variants from a single test line. The developed proof-of-concept dual-label LFA was able to distinguish between the ascites fluid samples from diagnosed ovarian cancer patients (n = 10) and liver cirrhosis ascites fluid samples (n = 3) used as a negative control. The analytical sensitivity of CA125-STn for the dual-label LFA was 1.8 U/ml in buffer and 3.6 U/ml in ascites fluid matrix. Here we demonstrate a novel approach of spectrally separated measurement of STn-glycosylated forms of two different cancer-associated protein biomarkers by using UCNP reporter technology.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2025-18-03 at 12:33